Arrhythmias & electrophysiology

Cardioneuroablation for reflex asystolic syncope: Mid-term safety, efficacy, and patient’s acceptance

Heart RhythmPublished Prospective observational study

Authors' conclusion

Mid-term efficacy of CNA exceeds 80%, and acute complications are absent. The most frequent mid-term chronic complication is inappropriate sinus tachycardia, which in 7% required chronic treatment. The procedure is well accepted by patients.

Study context

Population
Patients with reflex asystolic syncope treated 2016–2022 with ≥1-year follow-up (mean age 39 ± 13 years; 58% female)
Participants
115 consecutive patients
Outcome
Mid-term safety, efficacy (freedom from syncope) and patient acceptance of CNA
Follow-up
Median 28 months (range 12-75)
Methodological detailssingle-centre, consecutive patients
  • Single-centre
  • Consecutive patients

Main finding

As reported in the abstract

Freedom from syncope

Remained free from syncope after cardioneuroablation (CNA)

95

83%

Observational data: associations, not effects.

Further findings

OutcomeValues
Repeated CNA / pacemaker implantationEvents/value = repeated CNACNA 3% · Pacemaker implantation 5 (4%)
Patient acceptanceStated that it was worth undergoing the procedureCNA 96%

Syncope burden in patients with recurrence (n = 20, 17%)

Syncope burden decreased from mean 17 (median 6.5) to 3.75 (median 2.5) episodes
P = 0.015

Pacing system removal

Pacing system removal possible
9 of 10 patients

Safety

OutcomeValues
Dyspnea, chronic chest pain, decreased exercise capacity (mild)CNA 14%

Sinus rhythm acceleration (heart rate)

Heart rate from 60 ± 14 bpm to 90 ± 16 bpm
P < 0.0001
Symptomatic
31 patients (27%)
Required chronic beta-blocker and/or ivabradine
8 patients (7%)
Sinus node modification necessary
1 patient

Original publication

Cardioneuroablation for reflex asystolic syncope: Mid-term safety, efficacy, and patient’s acceptance. Heart Rhythm. Published 29 November 2023. doi:10.1016/j.hrthm.2023.11.022

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.